{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:48:21Z","timestamp":1779328101077,"version":"3.51.4"},"reference-count":44,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1517\/13543784.8.4.443","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T18:30:45Z","timestamp":1115231445000},"page":"443-452","source":"Crossref","is-referenced-by-count":15,"title":["Risperidone (Risperdal): clinical experience with a new antipsychosis drug"],"prefix":"10.1517","volume":"8","author":[{"given":"Nicholas A","family":"Keks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Culhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5694\/j.1326-5377.1989.tb101259.x","volume":"151","author":"KEKS NA","year":"1989","journal-title":"Med. J. Australia"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601043340109"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1996.tb05944.x"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.7.902"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/16.4.551"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90682-4"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1126\/science.6136093"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb01607.x"},{"key":"CIT0021","first-page":"685","volume":"244","author":"JANSSEN PAJ, NIEMEEGERS CJE, AWOUTERS F","year":"1988","journal-title":"J. Pharmacol Exp. Ther."},{"key":"CIT0023","first-page":"S3\u2013S17","volume":"2","author":"LEYSEN JE JANSSEN PMF","year":"1998","journal-title":"Int. J. Psychiat. Clin. Pract."},{"issue":"1","key":"CIT0025","first-page":"93","volume":"26","author":"KEKS N","year":"1996","journal-title":"Austr. J. Hosp. Pharm."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820070032005"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/BF02251280"},{"key":"CIT0030","first-page":"S39\u2013S42","volume":"2","author":"FARDE L","year":"1998","journal-title":"Intl. J. Phychiat. Clin. Pract."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.146"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014355"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199302000-00004"},{"key":"CIT0036","first-page":"295","volume":"85","author":"CLAUS A","year":"1992","journal-title":"DE CUYPER H et al.: Risperidone versus haloperidol in the treatment of chronic schizo-phrenic inpatients: a multicentre double-blind com-parative study. Acta. Psychiatr. Scand."},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.6.825"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1993.34.2.179"},{"key":"CIT0040","first-page":"712","volume":"166","author":"PEUSKENS J FOR THE RISPERIDONE STUDY GROUP","year":"1995","journal-title":"Br. J. Phychial"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03480.x"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92716-2"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1996.tb00030.x"},{"issue":"1","key":"CIT0045","first-page":"58","volume":"20","author":"DAVIES A","year":"1998","journal-title":"Meta-analysis of efficacy and safety. Clin. Ther."},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1177\/026988119701100116"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199511000-00001"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199710000-00010"},{"key":"CIT0050","doi-asserted-by":"crossref","unstructured":"CONLEY RR, BRECHER M. THE RISPERIDONE\/OLANZAP-INE STUDY GROUP: Risperidone versus olanzapine in patients with schizophrenia or schizoaffective disor-der. ECNP, Paris, France (November 1998).","DOI":"10.1016\/S0924-977X(98)80413-6"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80082-3"},{"key":"CIT0052","first-page":"799","volume":"154","author":"FOSTER GM","year":"1997","journal-title":"J. PhychiaL."},{"key":"CIT0055","first-page":"917","volume":"15","author":"ADDINGTON DE","year":"1993","journal-title":"Clin. Ther."},{"issue":"0","key":"CIT0057","first-page":"97","volume":"14","author":"FOSTER RH","year":"1998","journal-title":"Phar-macoecon."},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199611050-00005"},{"key":"CIT0060","unstructured":"CHAN Y, VOTOLATO N, NASRALLAH H: Pharma-coeconomic comparisons of risperidone and olanzap-ine during acute inpatient treatment of schizophrenia. Presented at CINP, Glasgow, UK (July 1998)."},{"issue":"9","key":"CIT0061","first-page":"57","volume":"57","author":"MARDER SR","year":"1996","journal-title":"J.Clin. PhychiaL"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199804000-00012"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.10.2.220"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.2190\/JJY8-P3YW-MN9Y-WBTX"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199804000-00014"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199711000-00006"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.2.245"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.4.499"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.8.4.443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T06:35:01Z","timestamp":1586241301000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.8.4.443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1999,4]]}},"alternative-id":["10.1517\/13543784.8.4.443"],"URL":"https:\/\/doi.org\/10.1517\/13543784.8.4.443","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}